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Abstract 
Background: Pachyderma is defined as severely thickened skin with deep folds and is occa-
sionally observed with primary cutaneous NK and T-cell lymphoma (pCNKTCL), primary cuta-
neous B-cell lymphoma (pCBCL), and leukemia cutis (LC). Aim: To describe the clinical, histo-
logical, and therapeutic particularities of a series of pCNKTCL, pCBCL, and LC patients with 
pachyderma. Results: In a series of pCNKTCL (n = 70), pCBCL (n = 12), and LC (n = 2) pa-
tients followed up during 9 years, 6 cases of pachyderma were observed. Pachyderma oc-
curred on the arms (n = 2), thighs (n = 1), forehead (n = 1), and face (n = 2). The mean age of 
the patients was 69 years (51–82). The stages were erythrodermic (T4) mycosis fungoides 
(MF) (n = 1), folliculotropic MF (FMF) (n = 2), classic (T2) MF (n = 2), and chronic myeloid 
leukemia (n = 1). The erythrodermic MF patient with acute pachyderma on the right arm 
responded rapidly to oral steroids. The other cases were indolent, appeared progressively, 
and were highly treatment resistant. Histology revealed dense dermal neoplastic infiltration. 
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The immunohistological profile of the pachydermic lesions was similar to common MF and 
LC. Conclusion: Pachyderma is an atypical manifestation of MF and LC and may occur on the 
face (FMF) or the extremities (MF). The rapidly appearing pachyderma may be transitory and 
responds readily to oral steroids. © 2017 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Pachyderma is defined as substantially thickened skin with deep folds, as observed in 
pachyderm animals such as elephants, rhinoceros, and hippopotami. Pachyderma in humans 
may be observed in several medical conditions – among others, during chronic severe lym-
phatic insufficiency with lymphedema [1], pachydermoperiostosis (Touraine-Solente-Golé 
syndrome) [2], keratitis-ichthyosis-deafness syndrome [3], congenital or secondary cutis 
verticis gyrata [4, 5], crusted scabies [6], severely infiltrated scleromyxedema [7], especially 
of the face, and lepromatous leprosy, presenting as leonine facies. White sponge nevus is 
considered a manifestation of pachyderma of the intraoral mucosa. 
Mycosis fungoides (MF) is the most frequently encountered manifestation of primary 
cutaneous NK and T-cell lymphoma (pCNKTCL). Leukemia cutis (LC) is a nonspecific term 
used for cutaneous manifestations of any type of leukemia. Pachyderma occurring in pa-
tients with pCNKTCL [8] and LC [9, 10] has exceptionally been reported. Pachyderma in 
pCNKTCL patients classically presents as leonine facies and seems restricted to patients with 
facial folliculotropic MF (FMF) [11]. Leonine facies has also been described in a patient suf-
fering from chronic primary cutaneous B-cell lymphoma (pCBCL) [12]. 
The mechanisms and clinical patterns of pachyderma during pCNKTCL and LC are not 
well elucidated. The aim of this study was to describe the clinical particularities as well as 
the histological and therapeutic features in a series of pCNKTCL, pCBCL, and LC patients 
presenting with pachyderma. 
Subjects and Methods 
The study was performed in accordance with the Declaration of Helsinki (version 2013). 
The institutional ethics committee approved the design of the study. The patients were in-
formed about the procedures and were invited to fill in a medical questionnaire. All the pa-
tients signed the informed consent forms. 
A cohort of 84 patients with pCNKTCL (n = 70), pCBCL (n = 12), or LC (n = 2) were in-
cluded and prospectively followed up during 9 years. In this patient series, the number of 
patients with pachyderma was assessed. Pachyderma was defined as the presence of thick 
continuous and concatenated skin folds with prominent convexities and furrowed creases. 
Age, gender, the anatomical site, the extension and duration of the pachydermic lesions, the 
underlying disease stage, the pachydermic disease course, and the treatments were record-
ed for all the cases with pachyderma. A skin biopsy was performed on all pachyderma pa-
tients under local anesthesia for histological and immunohistological assessments as well as 
for PCR to search for monoclonal TCR rearrangement. 
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Among the 84 patients, 6 fulfilled the above-mentioned criteria for pachyderma during 
the observation period. The anatomical sites were the arms (n = 2), buttocks (n = 1), fore-
head (n = 1), and face (n = 2). The mean age of the pachyderma patients was 69 years (min. 
51, max. 82). The disease stages at the moment of diagnosis of pachyderma were erythro-
dermic (T4 stage) MF (n = 1), FMF (n = 2), classic type (T1/2 stage) MF (n = 2), and chronic 
myeloid leukemia (n = 1). All the MF and FMF patients had a long disease history of 
pCNKTCL. The extension of the pachyderma of the face and forehead corresponded precisely 
to the skin area involved in FMF and LC. In contrast, the pachyderma on the extremities only 
involved part of the total cutaneous extension seen in MF. The pachydermic infiltration of 
the arms appeared quickly and rapidly responded to oral steroids (Fig. 1). In contrast, the 
lesions of the buttocks and the face (Fig. 2) were indolent, appeared progressively, and were 
highly treatment resistant. The histological examination (Fig. 1, 2) of the pachydermic le-
sions revealed a dense inflammatory and neoplastic infiltrate of the entire dermis with ex-
tension to the epidermis and sometimes the hypodermis, but this was otherwise not differ-
ent from common MF, FMF, and myeloid LC (MLC). The immunohistological profile revealed 
a dense CD3+, CD4+, CD45R0+, and CD8– infiltrate (Fig. 2). In all the MF and FMF cases, TCR 
monoclonality was observed by PCR. This monoclonality was identical to that previously 
evidenced during the initial workup at diagnosis. In the MLC patient, a dense myeloid infil-
trate of the dermis was noted (Fig. 2). The individual patient data are presented in Table 1. 
The rapid appearance of the pachyderma on the arms (Fig. 1) encouraged the use of sys-
temic oral steroids (methylprednisolone, 125 mg progressively tapered over 2 weeks) and 
was followed by total regression of the pachydermic aspect (Fig. 1). 
Discussion 
Besides classic MF, an important array of atypical MF presentations are encountered, in-
cluding FMF and syringotropic, verrucous, bullous, vesicular, pustular, granulomatous, alo-
pecic, palmoplantar, unilesional, “tumeur d’emblée”-type, poikilodermic, hypopigmented, 
hyperpigmented, interstitial, papillomatous, ichthyosiform, mucosal, and pigmented purpu-
ric MF [8, 13, 14]. Transitions from one form to another and coexistence of different forms 
may be observed. Hence, it is not without reason that MF is often called the great mimicker 
[8, 13, 14]. 
A slow-appearing and chronic form of pachyderma (leonine facies) may be encountered 
in patients suffering from FMF of the face [11]. It appears as hypertrophy and progressive 
folding of the facial skin, in particular the forehead. FMF-associated leonine facies is ob-
served in stage IV cutaneous T-cell lymphoma and is often accompanied by some degree of 
blood involvement. Treatment with local electron beam therapy was recommended [11]. 
Although the clinical picture of pachyderma is relatively unequivocal, there is no clear 
histological definition of pachyderma, as the thickening may have various origins. Tumoral 
infiltration of neoplastic lymphocytes seems the main reason for pachyderma in FMF [11] 
and MF, tumoral infiltration of leukemic cells in LC [15], granulomatous infiltration in the 
case of leprosy, lymphatic and edematous stowage in patients with lymphatic insufficiency 
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[1] or scleromyxedema [7], and dense lymphocytic infiltration in the case of prurigo and 
Norwegian scabies [6]. Granulomatous slack skin may also present a pachydermic aspect, 
particularly in the skin folds. The folds are caused by a granulomatous infiltration of the 
dermis by atypical lymphocytes. The folds are even more accentuated due to enzymatic deg-
radation of the elastic fibers, enzymes released by tumoral cells [12, 13]. The two cases of 
pachyderma affecting the face are similar to the description of FMF-associated leonine facies 
[11]. 
In conclusion, chronic and transitory forms of pachyderma on the extremities may be 
encountered in patients with long-standing MF and should be recognized as one of the mani-
festations of MF. Oral steroids seem to represent a beneficial therapeutic option in rapidly 
appearing pachyderma. Chronic pachyderma on the face is associated with facial involve-
ment of FMF. 
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Fig. 1. a Pachyderma on the right arm. b Three weeks after treatment with oral steroids. c CD4+ rich and 
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Fig. 2. a Pachydermic infiltration of the forehead of the patient with myeloid leukemia cutis. b Pachyderma 
on the neck and in the shoulder area of the same patient. c Dense myeloid infiltrate extending over the 
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Table 1. Pachyderma patient demographics 
       












Treatment of  
pachyderma 
       
       
1 64/F FMF T1N0M0B0/ 
IA 
Front Chronic Photodynamic treatment 
2 82/M MF T4N1M0B0/ 
III 
Right arm Transient Oral steroids, MTX 
3 80/F MF T2N0M0B0/ 
IB 
Left arm Chronic Interferon + MTX 
4 51/M MLC FAB M2 Face, neck, 
shoulders 
Chronic Deceased 4 months after 
diagnosis 
5 62/M FMF T2N0M0B0/ 
IB 
Face Chronic Retinoids, RxT 
6 74/F MF T2N0M0B0/ 
IB 
Buttocks Chronic Topical steroids, MTX, RxT 
       
       
MF, mycosis fungoides, classic type; FMF, folliculotropic MF; MLC, myeloid leukemia cutis; FAB M2, French-
American-British classification, acute myeloblastic leukemia with maturation; TNMB, tumor, node, 
metastasis, blood; MTX, methotrexate; RxT, radiation therapy. 
 
 
 
 
 
